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Enteroaggregative Escherichia coli (EAEC) is an emerging enteric pathogen that causes acute and chronic
diarrhea among children, human immunodeficiency virus-infected patients, and travelers to developing regions of
the world. The pathogenesis of EAEC strains involves the production of biofilm. In this study, we determined the
association between presence of putative EAEC virulence genes and biofilm formation in 57 EAEC isolates (as
defined by HEp-2 adherence) from travelers with diarrhea and in 18 EAEC isolates from travelers without diarrhea.
Twelve nondiarrheagenic E. coli isolates from healthy travelers were used as controls. Biofilm formation was
measured by using a microtiter plate assay with the crystal violet staining method, and the presence of the putative
EAEC virulence genes aap, aatA, aggR, astA, irp2, pet, set1A, and shf was determined by PCR. EAEC isolates were
more likely to produce biofilm than nondiarrheagenic E. coli isolates (P 0.027), and the production of biofilm was
associated with the virulence genes aggR, set1A, aatA, and irp2, which were found in 16 (40%), 17 (43%), 10 (25%),
and 27 (68%) of the biofilm producers versus only 4 (11%), 6 (6%), 2 (6%), and 15 (43%) in non-biofilm producers
(P  0.008 for aggR, P  0.0004 for set1A, P  0.029 for aatA, and P  0.04 for irp2). Although the proportion of
EAEC isolates producing biofilm in patients with diarrhea (51%) was similar to that in patients without diarrhea
(61%), biofilm production was related to the carriage of aggR (P 0.015), set1A (P 0.001), and aatA (P 0.025).
Since aggR is a master regulator of EAEC, the presence of aap (P 0.004), astA (P 0.001), irp2 (P 0.0006), pet
(P  0.002), and set1A (P  0.014) in an aggR versus an aggR-lacking background was investigated and was also
found to be associated with biofilm production. This study suggests that biofilm formation is a common phenom-
enon among EAEC isolates derived from travelers with or without diarrhea and that multiple genes associated with
biofilm formation are regulated by aggR.
Bacterial diarrhea is one of the most common causes of
morbidity and mortality among infants and children of devel-
oping nations (4, 21). Diarrheagenic Escherichia coli is the
most commonly identified pathogen, and at least five distinct
pathotypes have been characterized, including enterotoxigenic
E. coli (ETEC), enteropathogenic E. coli, enterohemorrhagic
E. coli, enteroinvasive E. coli, and enteroaggregative E. coli
(EAEC). EAEC is an emerging food-borne pathotype that can
cause acute and persistent diarrhea in children, human immu-
nodeficiency virus-infected persons, and international travelers
(1, 2, 15, 16, 24, 27). EAEC has been associated with diarrhea
in both developing and industrialized countries (13, 24), in-
cluding the United States (5, 24), and sometimes causes large
outbreaks of gastrointestinal illness (14).
Aggregative adherence (AA) to the intestinal mucosa is the
first step in EAEC pathogenesis (23). EAEC adheres to the
small and large intestinal mucosal surface and stimulates mu-
cus secretion, forming a thick aggregating biofilm (12, 21, 30,
32, 33). After adhesion, multiplication, and colonization on a
surface (6), the bacteria surround themselves with exopoly-
meric substances and recruit more cells to form microcolonies
interspersed with fluid-filled channels. Because of the re-
stricted penetration of antimicrobials, decreased growth rate,
and the expression of possible resistance genes, colonies in
biofilm are not easily eradicated by bactericidal antibiotics (6)
and may also be protected from attack by the intestinal im-
mune system, resulting in prolonged infections.
The genetic determinants involved in biofilm production by
EAEC have just begun to be understood (8, 18, 30, 34). Several
virulence factors such as aggA, aggR, and aap (dispersin) are
important in EAEC adherence to the intestinal mucosa and in
stimulating biofilm formation (29, 30, 34). In addition, Sheikh
et al. (30) have shown that fis and yafK, through the activation
of aggR, are also important in biofilm formation. Several other
genes, including aatA, pet (plasmid encoded toxins), ShET1
(Shigella enterotoxins), irp2 (yersiniabactin biosynthesis gene),
and shf (cryptic open reading frame), are also thought to be
involved in EAEC pathogenesis (7, 9, 11, 29, 31). The relation-
ship of known or putative EAEC virulence genes and biofilm
formation in isolates derived from subjects with travelers’ di-
arrhea has not been studied.
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MATERIALS AND METHODS
Study population and microbiology. Stool samples were collected during the
period from 1999 to 2004 from travelers from industrialized countries with
diarrhea (n  57) and without diarrhea (n  30) during short-term stays in
Mexico (57 isolates), India (10 isolates), and Guatemala (8 isolates) (10) and
studied for the presence of enteric pathogens as previously described (19). A
total of 75 EAEC isolates (57 from travelers with diarrhea and 18 from travelers
without diarrhea) derived from fresh stool culture and stored in peptone stabs
were used in the present study. Twelve E. coli isolates from subjects without
diarrhea that did not demonstrate HEp-2 adherence and did not carry genes for
ETEC heat-labile toxin (LT) and/or heat-stable toxin (ST) production were also
used in the present study as nondiarrheagenic E. coli controls. The study was
approved by the University of Texas Committee for the Protection of Human
Subjects at the University of Texas Health Science Center at Houston, and
written informed consent was obtained from each subject.
Detection of virulence factors by PCR. E. coli isolates were picked from a
single colony grown on Luria broth agar plates. EAEC virulence factors were
identified by PCR using specific primers (Table 1) as described previously (7, 28),
including the putative virulence genes irp2 of Yersinia species (28) and shET1
(set1A) of Shigella (7), which have been previously identified in some EAEC
isolates.
Biofilm assay. To test for biofilm formation, isolates grown overnight in Luria
broth with 0.25% glucose at 37°C with agitation were diluted 1:100 in Dulbecco
modified Eagle medium plus 0.45% glucose, and 200 l of the bacterial suspen-
sion was inoculated into individual wells of sterile 96-well polystyrene microtiter
plates. After incubation at 18 h at 37°C, a modified biofilm assay was carried out
according to previously published methods (17), except that bacteria were fixed
with 200 l of Bouin fixative for 15 min at room temperature and rinsed once
with phosphate-buffered saline. The fixed bacterial cells were then stained with
0.5% crystal violet for 15 min at room temperature and rinsed thoroughly with
distilled water. After air drying, crystal violet was solubilized in 200 l of ethanol-
acetone (80:20 [vol/vol]) for 30 min, and the optical density at 570 nm (OD570)
was measured by using a microplate reader (MultiskanSpectrum, Thermo Lab-
systems, Vantaa, Finland). Each assay was performed in quadruplicate and
repeated on at least three different occasions. EAEC strain 042 served as a
positive control (30) for the strong biofilm producer, and the nonpathogenic
E. coli strains HS and E. coli DH5 served as negative controls for the non-
biofilm producer.
Statistical analysis. Statistical analyses were performed by using the Fisher
exact test and chi-square test for categorical data, while the nonparametric
Mann-Whitney test, as well as analysis of variance (GraphPad Prism 4) was
used for continuous variables. The median OD570 and interquartile range
values for clinical isolates were calculated by using GraphPad Prism 4 statis-
tical software.
(This study was presented in part at the 106th General Meeting of the Amer-
ican Society for Microbiology, 21 to 25 May 2006, Orlando, FL.)
RESULTS
Biofilm formation by EAEC isolates. The biofilm mean
OD570 values for the negative controls E. coli HS and E. coli
DH5 were 0.377  0.026 and 0.243  0.029, respectively,
whereas for the positive control EAEC 042 the mean OD570
value was 3.341  0.074. Based on OD570 readings after incu-
bation and crystal violet staining, E. coli isolates were deemed
biofilm formers if the OD570 readings exceeded the mean plus
two standard deviations of the E. coli HS and DH5 negative
control strains (i.e., 0.46). We also arbitrarily classified sam-
ples as strong biofilm (OD5701), weak biofilm (OD570  0.46
 1), and non-biofilm (OD570  0.46) producers (Fig. 1). For
the entire group of isolates, the OD570 readings ranged from
0.16 to 3.36 U (Fig. 1). Forty (53%) of the isolates were
classified as biofilm producers with a mean OD of 1.143 
0.744. Of the rest of the isolates, 35 (47%) were classified as
non-biofilm producers with a mean OD of 0.292  0.075.
Based on the definition given above, 40 of the 75 (53%) EAEC
isolates were biofilm producers; in contrast, only 2 of the 12
(17%) nondiarrheagenic E. coli isolates produced biofilm (P 
0.027; chi-squre test), and when they did it was of the weak
phenotype (Fig. 1). Among the 75 EAEC isolates, 16 (21%)
were strong biofilm (mean OD  1.852  0.722), 24 (32%)
were weak (mean OD  0.670  0.127), and 35 (47%) were
non-biofilm (mean OD  0.292  0.075) producers (Tables 2
and 3). Among 75 EAEC isolates, 31 (54%) of the 57 isolates
from Mexico, 5 (50%) of the 10 isolates from India, and 5
TABLE 1. Primers used in this study
Genea Putative function Primer sequence Ampliconsize (bp)
Accession no. and/or
reference Starting PCR conditions
aggR* Transcriptional activator 5-CTAATTGTACAATCGATGTA-3 308 Z18751 (7) 1 min at 94°C, 1 min at
for AAF/I and AAF/II 5-ATGAAGTAATTCTTGAAT-3 42°C, 1 min at 72°C
aap* Dispersin 5-ATGAAAAAAATTAAGTTTGTTATCTT-3 351 Z32523 1 min at 94°C, 1 min at
5-TTATTTAACCCATTCGGTTAGAGC-3 52°C, 1 min at 72°C
aatA* Dispersin transporter 5-CTGGCGAAAGACTGTATCAT-3 630 X81423 1 min at 94°C, 1 min at
protein/CVD432 5-CAATGTATAGAAATCCGCTGTT-3 55°C, 1 min at 72°C
astA EAST1 heat-stable toxin 5-ATGCCATCAACACAGTATAT-3 110 S81691 1 min at 94°C, 1 min at
5-GCGAGTGACGGCTTTGTAGT-3 55°C, 1 min at 72°C
pet Plasmid encoded toxin 5-ACTGGCGGACTCATTGCTGT-3 832 AFO56581 1 min at 94°C, 1 min at
5-GCGTTTTTCCGTTCCCTATT-3 55°C, 1 min at 72°C
shf Cryptic open reading 5-ACTTTCTCCCGAGACATTC-3 613 AF134403 (7) 1 min at 94°C, 1 min at
frame 5-CTTTAGCGGGAGCATTCAT-3 50°C, 1 min at 72°C
irp2† Yersiniabactin 5-AAGGATTCGCTGTTACCGGAC-3 264 Schubert et al. (28) 1 min at 94°C, 1 min at
biosynthesis 5-TCGTCGGGCAGCGTTTCTTCT-3 55°C, 1 min at 72°C
set1A† Shigella enterotoxin 1 5-TCACGCTACCATCAAAGA-3 309 AF097644 1 min at 94°C, 1 min at
5-TATCCCCCTTTGGTGGTA-3 55°C, 1 min at 72°C
a *, Plasmid-borne genes known to be regulated by AggR; †, chromosomal encoded gene.
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(62%) of the 8 isolates from Guatemala produced biofilm (the
P value was not significant [NS]; Fisher’s exact test).
Association between the presence of putative EAEC viru-
lence genes and biofilm formation. We observed an association
between the presence of aggR and biofilm formation. Of the 75
EAEC isolates, 16 (40%) of 40 the biofilm producers con-
tained aggR versus only 4 of 35 (11%) of the non-biofilm
producers (P  0.008; Fisher’s exact test) (Tables 2 and 3).
Among these isolates, aggR was detected in 8 of 16 (50%) of
the strong biofilm producers and in 8 of 24 (33%) of the
weak biofilm producers. We also identified an association
with the presence of the set1A gene and biofilm production,
which was present in 17 of 40 (43%) of biofilm producers
versus 2 of 35 (6%) of non-biofilm producers (P  0.0004;
Fisher’s exact test) (Tables 2 and 3). Of 40 biofilm-positive
isolates, 10 (25%) carried the aatA gene compared to only 2
of 35 (6%) biofilm-negative isolates (P  0.029; Fisher’s
exact test) (Tables 2 and 3).
Of 40 biofilm producers, 27 (68%) carried irp2 versus 15
(43%) of 35 non-biofilm producers (P  0.038; Fisher’s exact
FIG. 1. Biofilm formation by EAEC isolates derived from travelers’ with diarrhea or without diarrhea. Biofilm formation on polystyrene surface
after 18 h was assessed by crystal violet staining. Each dot indicates the mean values with standard deviations. The biofilm assay was performed
three times, with quadruplicates in each assay. Biofilm formation by nondiarrheagenic E. coli isolates was also tested. E coli isolates were deemed
biofilm formers if the OD570 readings exceeded the mean plus two standard deviations of the E. coli strains HS and DH5 negative control for
non-biofilm producers (i.e., 0.46).
TABLE 2. Occurrence of biofilm formation (BF) and presence of
various genes in E. coli isolates from U.S. travelers to Mexico,
India, and Guatemala in EAEC isolates (n  75)
Genea
Biofilm formation [no. of isolates (%)]b
P cStrong
(n  16)
Weak
(n  24)
Non-BF
(n  35)
All BF
(n  40)
aggR* 8 (50) 8 (33) 4 (11) 16 (40) 0.008
set1A† 8 (50) 9 (38) 2 (6) 17 (43) 0.0004
aatA* 6 (38) 4 (17) 2 (6) 10 (25) 0.029
irp2† 9 (56) 18 (75) 15 (43) 27 (68) 0.038
aap* 6 (38) 7 (29) 7 (20) 13 (33) 0.298
pet 8 (50) 8 (33) 8 (23) 16 (40) 0.14
shf 3 (19) 7 (29) 14 (40) 10 (25) 0.217
astA 12 (75) 14 (58) 25 (71) 26 (65) 0.624
a *, plasmid-borne genes known to be regulated by AggR; †, chromosomal
encoded gene.
b Strong, OD570  1; weak, OD570  0.46  1; Non-BF, OD570  0.46.
c P values represent biofilm formers versus non-biofilm formers (Fisher’s exact
test).
TABLE 3. Occurrence of biofilm formation (BF) and presence of
various genes in E. coli isolates from U.S. travelers to Mexico,
India, and Guatemala in non-EAEC isolates (n  12)
Genea
Biofilm formation [no. of isolates (%)]b
PcStrong
(n  0)
Weak
(n  2)
Non-BF
(n  10)
All BF
(n  2)
aggR* 0 0 0 0 1.000
set1A† 0 0 4 (40) 0 0.515
aatA* 0 0 0 0 1.000
irp2† 0 1 (50) 8 (80) 1 (50) 0.455
aap* 0 0 0 0 1.000
pet 0 0 3 (30) 0 1.000
shf 0 1 (50) 2 (30) 1 (50) 0.455
astA 0 1 (50) 4 (40) 1 (50) 1.000
a *, plasmid-borne genes known to be regulated by AggR; †, chromosomal
encoded gene.
b Strong, OD570  1; weak, OD570  0.46  1; Non-BF, OD570  0.46.
c P values represent biofilm formers versus non-biofilm formers (Fisher’s exact
test).
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test) (Tables 2 and 3). No significant relationship between the
presence of other putative virulence factors, including aap,
astA, pet,and shf, and the biofilm phenotype were identified.
Thirteen (13 of 40 or 32%) biofilm-producing EAEC isolates
carried four genes (aggR, set1A, aatA, and/or aap) simulta-
neously in contrast to none (0 of 35) of the non-biofilm-pro-
ducing EAEC isolates (P  0.0001; Fisher’s exact test). Of
these 13 biofilm-producing isolates, 10, 2, and 1 isolate were
derived from Mexico, India, and Guatemala, respectively (P 
NS; Fisher’s exact test). Of interest, 10 of the 12 nondiarrhea-
genic E. coli isolates had at least one or more of the genes
studied (set1A, irp2, pet, astA, and shf) (Tables 2 and 3); how-
ever, they demonstrated weak or no biofilm formation.
The median biofilm OD value was significantly higher in
biofilm producers carrying aggR (median OD of 0.72 versus
0.40), set1A (median OD of 0.86 versus 0.40), and aatA (me-
dian OD of 1.376 versus 0.44) than in isolates lacking these
genes (P  0.001 for aggR; P  0.0003 for set1A; and P  0.01
for aatA; Mann-Whitney test). In contrast, no significant asso-
ciation between biofilm and carriage of the aap, astA, pet, and
shf genes were observed.
Association of biofilm and virulence genes with diarrhea. As
shown in the Tables 4 and 5, the proportion of EAEC isolates
producing biofilm from patients with diarrhea (29 of 57 [51%])
was similar to that of subjects without travelers’ diarrhea (11 of
18 [61%]; P  NS; Fisher’s exact test), and biofilm production
by EAEC isolates from travelers’ diarrhea was related to the
carriage of virulence genes, particularly aggR, set1A, and aatA
(P  0.015 for aggR, P  0.001 for set1A, and P  0.025 for
aatA; Fisher’s exact test).
Role of AggR regulator and biofilm formation. Since AggR
is a master regulator in the pAA plasmid, the relatedness of
aggR to other genes was studied. Twelve biofilm producers had
both aggR and set1A genes (eight strong, six weak), and none of
non-biofilm producers had both these genes together. How-
ever, 20 biofilm producers (5 strong, 15 weak) and 34 non-
biofilm producers did not possess both genes (P  0.0001;
Fisher’s exact test). The presence of aap, astA, irp2, pet, and
set1A virulence genes in the aggR background for biofilm pro-
duction showed that the presence of these genes was associ-
ated with biofilm as long as aggR was also present. The pooled
median biofilm ODs of set1A/aggR versus set1A/aggR	
(P  0.014), aap/aggR versus aap/aggR	 (P  0.004),
astA/aggR versus astA/aggR	 (P  0.0019), irp2/aggR
versus irp2/aggR	 (P  0.0006), and pet/aggR versus
pet/aggR	 (P  0.0028) were statistically significant (Mann-
Whitney test) (Fig. 2).
DISCUSSION
The objective of this study was to determine the occurrence
of various EAEC virulence factors and of biofilm formation
among clinical isolates of EAEC collected from travelers from
industrialized countries to Mexico, India, and Guatemala dur-
ing short-terms stays. Of 75 EAEC isolates, 45 (53%) produced
biofilm on an abiotic surface, which is lower than the rates
reported by others (34) and may be due to our more strin-
gent definition of biofilm formation or to differences in
study design. In contrast to the findings of a previous study
(34) wherein isolates were initially screened for biofilm and
then characterized for aggregative phenotype, we initially
screened for the aggregative phenotype and then character-
ized the isolates for biofilm formation. The frequency of
biofilm formation by EAEC versus nondiarrheagenic E. coli
isolates was significant, confirming that biofilm formation is
more common in EAEC isolates than in nondiarrheagenic
E. coli isolates (30, 34).
Isolates carrying aggR alone or in combination with other
virulence genes (so-called typical EAEC) were strongly asso-
ciated with biofilm formation. aggR is an EAEC master regu-
lator formerly described as a transcriptional activator for
AAF/I expression (19, 20) and later proved also to be required
for AAF/II expression (9). Although other investigators have
reported that no correlation exists between aggR and biofilm
formation (26, 30), our findings are consistent with the work of
Wakimoto et al. (34). In a related study, EAEC adhesins were
found to be allelic in nature, and biofilm formation was shared
by all members of the AAF family among Indian isolates (3).
Taken together, these results suggest the sequence of factors
AggR3 AAF allele3 biofilm production though other path-
ways can produce the same phenotype.
We also investigated the relationship of dispersin and its
transporter in biofilm formation. Dispersin is a 10-kDa se-
creted protein coded by the aap gene that coats the bacterial
TABLE 5. Incidence of biofilm (BF) formation and the presence
of various genes among EAEC isolates from patients without
diarrhea (n  18)
Genea
Biofilm formation [no. of isolates (%)]
Pb
BF (n  11) BF	 (n  7)
aggR* 4 (36) 1 (14) 0.596
set1A† 3 (27) 0 0.245
aatA* 2 (18) 1 (14) 1.000
irp2† 8 (73) 4 (57) 0.627
aap† 4 (36) 2 (29) 1.000
pet 4 (36) 3 (43) 1.000
shf 1 (9) 3 (43) 0.245
astA 3 (27) 3 (43) 0.627
a *, plasmid-borne genes known to be regulated by AggR; †, chromosomal
encoded gene.
b P values represent biofilm formers versus non-biofilm formers (Fisher’s exact
test).
TABLE 4. Incidence of biofilm (BF) formation and the presence
of various genes among EAEC isolates from patients
with diarrhea (n  57)
Genea
Biofilm formation [no. of isolates (%)]
Pb
BF (n  29) BF	 (n  28)
aggR* 12 (41) 3 (11) 0.015
set1A† 14 (48) 2 (7) 0.001
aatA* 8 (27) 1 (4) 0.025
irp2† 19 (65) 11 (39) 0.065
aap† 9 (31) 5 (18) 0.360
pet 12 (41) 5 (18) 0.082
shf 9 (31) 11 (39) 0.585
astA 23 (79) 22 (79) 1.000
a *, plasmid-borne genes known to be regulated by AggR; †, chromosomal
encoded gene.
b P values represent biofilm formers versus non-biofilm formers (Fisher’s exact
test).
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surface and was selected for study since this protein promotes
the dispersal of EAEC on the intestinal mucosa (29). Biofilm
formation also correlated with the presence of the aatA gene
that codes for a transporter protein that is a homolog of E. coli
outer membrane protein, TolC (22). This was also of interest
to us because the transporter facilitates the export of dispersin
across the outer membrane in EAEC (29) and is the target for
probe CVD 432, which is widely used to identify EAEC by
molecular methods.
A novel finding in our study was the fact that the chromo-
somally located genes, set1A (Shigella enterotoxin 1) and irp2
(yersiniabactin biosynthesis gene) were also associated with
EAEC biofilm production. set1A encodes an oligomeric en-
terotoxin, ShET1 (7, 11) and it contributes to secretory diar-
rhea caused by EAEC and Shigella infections. EAEC strains
carrying set1A have been associated with diarrhea in Brazilian
children and adult travelers from Spain (25). irp2 in turn en-
codes a protein involved in yersiniabactin expression and is
designated iron-repressible high-molecular-weight protein 2
(Irp2) (7, 28). irp2 represents part of an unstable pathogenicity
island that was acquired as a result of a horizontal transfer.
Since set1A is located on the same island as a cluster of AggR-
regulated genes, the relationship may be coincidental since it
travels together with other putative virulence genes involved in
biofilm formation.
In the present study, the proportion of EAEC isolates that
were biofilm producers was similar in travelers with diarrhea
and in travelers with asymptomatic colonization (2) and may
explain in part the ability of EAEC to cause chronic coloniza-
tion (1).
Since aggR is a master regulator that controls both plasmid
and chromosomally encoded genes in EAEC, the biofilm for-
mation ability of EAEC isolates carrying aap, astA, irp2, pet,
and set1A with or without an aggR background was examined.
EAEC isolates possessing the aap, astA, irp2, pet, and set1A
genes in an aggR background produced more biofilm than
those with an aggR-lacking background. This suggests that
aggR regulates other genes needed for biofilm formation in
EAEC. Recently, Nataro and Dudley have shown that AggR
not only controls the plasmid-borne AAF fimbriae but also
chromosomal genes located on an island located at 94 min of
the EAEC chromosome (E. Dudley and J. Nataro, unpub-
lished results). Further, it seems that additional genes are also
under the control of aggR such as aatA (the dispersin trans-
porter) and aap (dispersin). Sheikh et al. (30) have proved that
the Fis protein contributes to biofilm production through
AAF/II biogenesis, apparently by the activation of aggR expres-
sion.
Nine HEp-2 adherent isolates produced biofilm but did not
carry either aggR, or aatA, or irp2, or set1A genes, indicating
that there are additional factors involved in biofilm production
in EAEC. It has recently been shown that atypical EAEC
strain C1096 harboring Incl1 plasmid encoding a type IV pilus
can contribute to biofilm formation (8). Additional work is
needed to characterize HEp-2-adherent, biofilm-forming
EAEC strains that are atypical (negative for aggR).
In summary, the present study suggests that biofilm forma-
tion is a common phenomenon among EAEC isolates derived
from travelers with or without diarrhea. In vitro biofilm pro-
duction from EAEC isolates is associated with aggR, and its
regulated genes aatA, irp2, and set1A. Multiple EAEC genes
located on the plasmid, as well as on its chromosome, are
associated with biofilm formation.
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FIG. 2. Biofilm formation by EAEC isolates based on the presence of various genes in aggR background. Biofilm formation on a polystyrene
surface after 18 h was assessed by crystal violet staining. Values are based on pooled median biofilm OD570 values shown by the box-and-whiskers
plot which represents an upper quartile, median, and lower quartile.
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